PL343113A1 - C11 oxymyl and hydroxylamino prostaglandins useful as medicaments - Google Patents

C11 oxymyl and hydroxylamino prostaglandins useful as medicaments

Info

Publication number
PL343113A1
PL343113A1 PL99343113A PL34311399A PL343113A1 PL 343113 A1 PL343113 A1 PL 343113A1 PL 99343113 A PL99343113 A PL 99343113A PL 34311399 A PL34311399 A PL 34311399A PL 343113 A1 PL343113 A1 PL 343113A1
Authority
PL
Poland
Prior art keywords
oxymyl
medicaments
hydroxylamino
prostaglandins useful
useful
Prior art date
Application number
PL99343113A
Other languages
English (en)
Inventor
Mitchell Anthony Delong
Jack Snyder Amburgey Jr
John August Wos
Biswanath De
David Lindsey Soper
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL343113A1 publication Critical patent/PL343113A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/18Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL99343113A 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments PL343113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8007598P 1998-03-31 1998-03-31
PCT/IB1999/000478 WO1999050241A1 (en) 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments

Publications (1)

Publication Number Publication Date
PL343113A1 true PL343113A1 (en) 2001-07-30

Family

ID=22155104

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343113A PL343113A1 (en) 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments

Country Status (23)

Country Link
US (1) US6410780B1 (xx)
EP (1) EP1082299B1 (xx)
JP (1) JP2002509915A (xx)
KR (1) KR20010042286A (xx)
CN (1) CN1295560A (xx)
AR (1) AR020063A1 (xx)
AT (1) ATE270272T1 (xx)
AU (1) AU749796B2 (xx)
BR (1) BR9909267A (xx)
CA (1) CA2324343C (xx)
DE (1) DE69918433T2 (xx)
ES (1) ES2223180T3 (xx)
HU (1) HUP0102789A2 (xx)
ID (1) ID26699A (xx)
IL (1) IL138446A0 (xx)
NO (1) NO20004904L (xx)
NZ (1) NZ506853A (xx)
PE (1) PE20000350A1 (xx)
PL (1) PL343113A1 (xx)
SK (1) SK14732000A3 (xx)
TR (1) TR200002808T2 (xx)
WO (1) WO1999050241A1 (xx)
ZA (1) ZA992393B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20060135609A1 (en) 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN102101835B (zh) * 2009-12-16 2015-07-22 武汉启瑞药业有限公司 前列腺素衍生物及其中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776938A (en) 1958-05-28 1973-12-04 S Bergstrom Dihydro-pge1
US3636120A (en) * 1967-10-09 1972-01-18 Upjohn Co Prostaglandin e primary alcohols
US4011262A (en) 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
US4024179A (en) 1972-11-08 1977-05-17 Pfizer Inc. Substituted ω-pentanorprostaglandins
DE2460990A1 (de) 1974-12-21 1976-07-01 Hoechst Ag Neue prostaglandin-analoga und verfahren zu ihrer herstellung
GB1507211A (en) 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues
JPH0222226A (ja) * 1988-07-12 1990-01-25 Ono Pharmaceut Co Ltd Pgd類似化合物を有効成分として含有する骨疾患治療剤
JP2721414B2 (ja) 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体

Also Published As

Publication number Publication date
SK14732000A3 (sk) 2001-04-09
ZA992393B (en) 1999-09-03
EP1082299A1 (en) 2001-03-14
KR20010042286A (ko) 2001-05-25
TR200002808T2 (tr) 2001-01-22
PE20000350A1 (es) 2000-06-22
NO20004904D0 (no) 2000-09-29
ID26699A (id) 2001-02-01
ATE270272T1 (de) 2004-07-15
ES2223180T3 (es) 2005-02-16
WO1999050241A1 (en) 1999-10-07
CA2324343C (en) 2005-05-31
NO20004904L (no) 2000-11-29
JP2002509915A (ja) 2002-04-02
EP1082299B1 (en) 2004-06-30
AR020063A1 (es) 2002-04-10
CN1295560A (zh) 2001-05-16
CA2324343A1 (en) 1999-10-07
AU749796B2 (en) 2002-07-04
IL138446A0 (en) 2001-10-31
HUP0102789A2 (hu) 2001-12-28
US6410780B1 (en) 2002-06-25
AU3270199A (en) 1999-10-18
DE69918433D1 (de) 2004-08-05
DE69918433T2 (de) 2005-09-01
BR9909267A (pt) 2000-11-21
NZ506853A (en) 2002-09-27

Similar Documents

Publication Publication Date Title
GB2285446B (en) Thrombopoietin
IL133603A0 (en) Triazole compounds and the use thereof as dopamine-d3-ligands
ZA991951B (en) Compound and its use.
GR3029907T3 (en) Parasiticidal formulations that can be applied dermally
HK1043791A1 (en) Imidazole compounds and medicinal use thereof.
ZA956997B (en) Indoles as insecticides and acaricides.
ZA951374B (en) Ranitidine solid dosage form
GB2353767B (en) Evacuation refuge
PL343113A1 (en) C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
HUP0104866A2 (en) Organo-phosphorus compounds and their utilization
GB9823245D0 (en) Pectins and the preparation thereof
IL142777A0 (en) Organophosphorous compounds and the use thereof
HUP0103403A3 (en) C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists
AU6328799A (en) Organophosphorous compounds and use thereof
IL139335A0 (en) Thrombopoietin
GB9425238D0 (en) Tree stable
GB9908689D0 (en) Respirator
AU1546595A (en) Platform construction
GB9804901D0 (en) Respirators
ZA9410355B (en) Thrombopoietin
GB9426293D0 (en) Composition,compound and use
GB9422162D0 (en) Composition, compound and use
GB9510167D0 (en) Compound, preparation and use
GB9404200D0 (en) Compound, preparation and use
AU685969C (en) Indoles as insecticides and acaricides